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Heart perforation in patients with permanent cardiac
pacing – pilot personal observations
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A b s t r a c t
Introduction: Heart perforation is a rare complication of pacemaker (PM)/im p-
lantable cardioverter-defibrillator (ICD) implantation. 
Material and methods: In our clinic in 2005-2010, 6 patients with heart perfo-
ration were hospitalized (3 women, 3 men), mean age 58.6 ±20.8 years (17 to
73 years). The indication to PM/ICD implantation was tachy-brady syndrome in
3 cases, second-degree atrioventricular block, advanced with losses of con-
sciousness, vaso-vagal syndrome type II B with asystole lasting 12 s and recur-
rent non-sustained ventricular tachycardia in 1 patient. We analyzed patient’s
medical records, X-rays, echocardiography, computed tomography (CT) and pro-
cedure protocols.
Results: The incidence of heart perforation was 0.09%. Symptoms developed 
4 to 990 days (mean 186.3 ±394.3) after PM/ICD implantation. The perforation
site was found in the right atrial wall in 1 cases and the right ventricular wall
in 6 cases. The TTE revealed an accumulation of fluid in the pericardium over
10 mm behind the posterior wall of the left ventricle in all patients. The CT scan
confirmed perforation of the heart chambers (atrium and in 6 cases ventricle).
In 5 cases the whole device was removed by direct traction or percutaneous
lead extraction with pericardiocentesis when necessary (pericardium drainage
in 3 cases) while in 1 case cardiac surgery was needed. 
Conclusions: The perforating lead may be removed by direct traction in the oper-
ating room with cardiosurgical, anesthesiological and echocardiographical back-
up. In case of the lead perforation outside the pericardial sac or its atypical loca-
tion, cardiac surgery is a safer method. The most important diagnostic method
remains computed tomography.
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Introduction
Implantation of a pacemaker (PM)/cardioverter-defibrillator (ICD), as
well as reimplantation and repair operations, is associated with a low risk
of complications, which usually occur early after the procedure. Possible
complications include the following: PM pocket haematoma, stimulation
of the chest wall muscle, diaphragm, phrenic nerves, lead dislocations with-
in the heart, infections (bacterial endocarditis of the tricuspid valve, of the
lead tip area, pacemaker pocket), subclavian vein thrombosis and/or its
supplies, and in rare cases right ventricle or right atrium perforation with
possible tamponade symptoms. The most common late complication is
lead fracture, which requires its repair or removal. Another possible com-
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plication is PM dislocation under the skin (which
may cause decubitus or even skin necrosis) and
skin puncture by a lead or PM [1].
Heart perforation in patients after PM implanta-
tion is a rare but potentially fatal complication. It
may involve large veins, atrial or ventricular walls or
the coronary sinus. Perforations may be acute (up
to 24 h after implantation, which may lead to tam-
ponade or death), subacute, which occur up to 
1 month after implantation, or chronic, which appear
at a later time. Another classification distinguishes
between early (symptoms occur up to 1 month after
implantation) and delayed perforations. The esti-
mated rate of this complication is 1% and depends
mainly on the surgeon’s experience [2-13]. Main risk
factors are listed in Table I [1, 4, 5].
The paper presents cases of life-threatening sub-
acute heart tamponade and delayed perforations
in patients after PM/ICD and atrial/ventricular lead
implantation.
Material and methods
In our clinic in 2005-2010, 6 patients with heart
perforation were hospitalized (3 women, 3 men),
mean age 58.6 ±20.8 years (17 to 73 years). In 2 of
the patients, implantation was performed outside
our clinic. During this period 3600 PM and 1007 ICD
implantations were performed. Characteristics of
the patient population are presented in Table II.
We analysed patients’ medical records, physical
examination, X-rays, echocardiography, computed
tomography (CT) and protocols of the implantation
procedures.
Results
In the present study, the incidence of heart 
perforation was 0.09%. Symptoms developed 4 to
990 days (mean 186.3 ±394.3) after device implan-
tation. There was no case of acute heart tampon-
ade/perforation up to 24 h after implantation. The
perforation site was found in the right atrial wall
in one case and the right ventricular wall in 6 cas-
es (Figures 1-2). Ventricular leads were placed in
the right ventricular outflow tract and in 1 case 
in the apex. Atrial leads were placed in the right
auricle. Heart wall damage was caused by pacing
I. Type of lead, mode of stimulation, lead tip location
Temporary stimulation
Atrial stimulation
Active fixation
Defibrillator leads:
• Double spirals
• Number of shocks delivered
• Excessive length of the lead
• Small diameter of the lead
• High resistance (small tip surface)
• Apical position
II. Propriety of the heart muscle
Congestive cardiomyopathy
III. The elderly, women, patients with low body mass 
(< 20 kg/m2)
IV. Anticoagulation therapy and steroid use within 7 days 
of implantation
V. Chest trauma, especially soon after implantation
Table I. Risk factors of lead perforation
Parameter Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6    
Age [years] 70 73 67 60 65 17
Sex Male Male Female Female Male Female
Tachy-brady syndrome + + +
Second-degree atrioventricular block, +
advanced with losses of consciousness
Vaso-vagal syndrome type IIB with +
asystole lasting 12 s
Recurrent non-sustained ventricular +
tachycardia
Dual chamber pacemaker + + + + +
Dual chamber ICD +
Coronary heart disease + + + + +
Arterial hypertension + + + + +
Dyslipidaemia + + +
Hyperthyreosis + +
Diabetes mellitus + +
Obesity +
Table II. Characteristics of the patient population
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ventricular and atrial leads (Biotronik Setrox S60,
S53, Vitatron Crystalline, Medtronic CapSure-
FixNovus) in 5 cases and by a 1-coil defibrillator
lead (Medtro nic Sprint Quattro) in one case. All
leads were active fixation. Patients complained of
stabbing pain in the left side of the chest, in cre -
ased by movement (in 5 cases), dyspnoea (1 case),
diaphragm stimulation (1 case), or remained
asymptomatic (1 case). Standard follow-up of the
electrical parameters showed pacing failure (in 4 pa -
tients), and sensing failure (in 6 cases). Transtho-
racic echocardiography showed pericardial effusion
over 10 mm behind the posterior wall of the left
ventricle in the parasternal long-axis view in all
patients (Figure 3). Computed tomography scan-
ning confirmed heart perforation (of the atrium
and in 6 cases of the ventricle). In the operating
room, with full cardiac surgery and anaesthesiolo-
gy backup, the whole device was removed by direct
traction, with pericardiocentesis when necessary
(pericardium drainage in 3 cases) in 4 patients, and
in one case (Figure 4) cardiac surgical extraction
was used (in this patient, the lead penetrated the
pericardial sac, injuring the parietal pleura and end-
ed in the intercostal muscles, but without pneu-
mothorax); 1 patient with delayed perforation
underwent device removal by percutaneous lead
extraction outside our department in a centre spe-
cializing in percutaneous lead extractions. Five
patients had a new PM/ICD implanted, with lead
tip location different from the previous one. One
patient (patient no. 6) did not agree to have a new
PM implanted. 
Discussion
Heart perforation is a rare, but potentially fatal
complication of permanent cardiac pacing systems.
Subacute and chronic perforation may be asymp-
tomatic, or it may cause dangerous symptoms
resulting in death [2, 3, 9, 11, 13]. The common
symptoms are chest pain, chest muscle or
diaphragm contraction, hiccough, abdominal pain,
dyspnoea, faintness or losses of consciousness
(because of pacing failure), inadequate shocks of
the ICD, symptoms of heart failure or tamponade
[2, 3, 9, 12, 13]. Heart tamponade is a life-threaten-
ing complication, caused by rapid blood accumula-
tion in the pericardial sac. It leads to pressure
growth in the pericardium, which in turn impairs
blood return to the atria and ventricles, lowering
ejection volume and causing haemodynamic col-
lapse with symptoms of cardiogenic shock, arrhyth-
mias or death [10]. In our population, there was no
case of an acute heart tamponade.
The most common perforation symptoms
described in the literature are improper electro-
physiological parameters; however, there have been
cases with normal electrical function [1]. Failure of
the lead to pace (increased pacing threshold) or
sense (decreased R wave amplitude) or decreased
lead impedance may suggest perforation and
require further diagnosis [5, 7]. In our material, in
Figure 1. Transthoracic echocardiography view. Ven-
tricular lead penetrating the wall of the right ventricle
Figure 2. Computed tomography scan. Tips of both
atrial and ventricular leads outside the heart
Figure 3. Transthoracic echocardiography view. Peri-
cardial effusion up to 29 mm behind the left ven-
tricular lateral wall
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each case we observed a high pacing or sensing
threshold. 
Diagnostic methods in heart perforation involve
chest X-ray and fluoroscopy (to show lead disloca-
tion outside the border of the heart), transthoracic
and transoesophageal echocardiography (TTE and
TEE) (presence of the lead tip in the pericardium or
pericardial effusion). The most important diagnos-
tic method remains CT, which is the gold standard.
It reveals both lead dislocation and even small peri-
cardial effusion [4, 9, 12, 13]. Each of our patients
had pericardial effusion.
In case of symptomatic heart perforation, the
best method of treatment is extraction of the whole
device. Various techniques of lead removal are used
depending on the lead construction and the time
since its implantation [5]. Active fixation leads of
homogeneous diameter up to 2 years after implan-
tation (6 months in the case of defibrillator leads)
may be removed by direct traction, as in 4 of our
patients. In case of failure, Byrd dilatators are used.
Active fixation leads of uneven diameter and/or
implanted over 2 years before or other lead types
(passive fixation) and implanted over 1 year before
(6 months in the case of defibrillator leads) should
be removed by a classical set of Byrd dilatators [1,
5, 14], as occurred in our 1 patient with delayed per-
foration. 
Most authors believe that patients with heart
perforation should be transported to a centre spe-
cializing in percutaneous lead extraction and the
best treatment is direct traction or percutaneous
lead extraction in the operating room, with moni-
toring of basic life functions. Cardiosurgical, anaes-
thesiological and echocardiographic teams ready at
hand are always necessary [1, 5]. It is also advised
to have TEE monitoring during and after the oper-
ation. Percutaneous extraction of the perforating
lead, not requiring general anaesthesia, has been
performed in cases of a very high operation risk. 
American guidelines recommend surgical
removal of the perforating leads [6, 8]. The report-
ed cases of surgical lead removal were digestive
tract perforation, massive heart tamponade, and
atypical location of the perforating lead in the inter-
costal muscles [9, 12], as in our patient who
required cardiac surgical operation. 
In most of these cases, a new pacemaker was
implanted, placing the lead tip in a different loca-
tion than before. In the case of open surgery, epi-
cardial leads have been used [4].
Diagnosis should be based on the patient’s med-
ical records, telemetric control of electrical param-
eters and visual examinations. Computed tomog-
raphy remains the gold standard and it confirmed
perforation in all our patients. 
The main limitation of this study is the small
group: only 6 patients in 5 years. None of the
above-mentioned predictors appeared in our
patients with a significant frequency.
In conclusion, in case of symptomatic heart per-
foration, the best method of treatment is extrac-
tion of the whole device. The perforating lead may
be removed by direct traction in the operating room
with cardiosurgical, anaesthesiological and echocar-
diographic backup. In case of lead perforation out-
side the pericardial sac or its atypical location, car-
diac surgery is a safer method. The most important
diagnostic method remains CT. 
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